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About 30 to 40 % of random bred Hartley strain (1) and all strain 2 guinea 
pigs (2) recognize hapten-poly-I.-lysine conjugates (H-PLL) as antigens. Strain 
13 guinea pigs (2), mice, rats, and rabbits (3) do not make an immune response 
to these compounds. The immune response of guinea pigs to H-PLL conjugates 
has been shown to" be controlled by a  dominant autosomal gene (2, 4). Con- 
trasting with the strong anfigenicity of H-PLL conjugates in "genetic respond- 
ers," previous attempts to demonstrate an immune response to PLL itself in 
these  animals  have  failed  (5,  6),  confirming the  widely held belief  (3)  that 
homopolymers of L-amino acids are not antigenic. 
The capacity to form an immune response to H-PLL conjugates was initially 
believed to depend on the ability of "genetic responders" to metabolize the PLL 
carrier in a way required to induce an immune response, but it was established 
that neither the enzymatic digestion of the PLL molecule (7) nor its uptake by 
lymph node macrophages (8) was impaired in unresponsive guinea pigs. It was 
postulated  that if  the gene governing the  antigenicity of H-PLL controls a 
specific metabolic step on the PLL carrier prior to  the recognition of speci- 
ficity, this  step must involve the formation of an  unidentified immunogenic 
inducer (1, 7). However, the nature of the immunological specificity of the re- 
sponse to H-PLL conjugates led us to entertain the alternative possibility that 
this gene may control the recognition of the PLL specificity as an antigen. The 
immunological specificity of specifically isolated anti-2,4-dinitrophenyl-poly-L- 
lysine antibodies (DNP-PLL) was indeed shown to extend to the PLL carrier 
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(9), illustrating that in this system as in hapten-protein systems the anfihapten 
antibodies induced by the same hapten on different carriers have different im- 
munological specificities  (10). The marked carrier specificity involving the PLL 
molecule had already been observed in delayed hypersensitivity reactions to 
hapten-PLL conjugates (1). Studies on the immunological specificity of hapten 
systems emphasize the concept that antigenic determinants in these systems 
must necessarily involve both hapten and carrier. These considerations led us 
to a reevaluation of the hapten-carrier relationship in the hapten-PLL system 
and to consider the possibility that the single gene control of the response to 
hapten-PLL conjugates may involve the recognition of the partial specificity 
attributable to  the PLL carrier. The antigenicity of unconjugated PLL was 
therefore reinvestigated and this homopolymer was found to provoke a  very 
weak but definitely recognizable delayed hypersensitivity reaction in guinea 
pigs capable of responding to hapten-PLL conjugates. 
A related study, which also gives some insight into the nature of the genetic 
control of the immune response to H-PLL, was performed. In these investiga- 
tions we determined whether hapten-PLL conjugates could be shown to behave 
as a complex hapten in nonresponder guinea pigs ff mixed with an immunogenic 
carrier. The term hapten was originally proposed by Landsteiner (11) in a paper 
which characterized the immunological behavior of alcoholic extract of horse 
kidney which  although capable  of combining with Forssman antibody, was 
itself nonantigenic. It was found later that the nonantigenic Forssman antigen 
could be made antigenic for rabbits by simply mixing it with pig serum (12). 
Other materials such as Wasserman antigens and other lipid antigens were also 
shown to display similar behavior  (13,  14).  Although the  mechanism of this 
phenomenon was and is not clearly understood, the term "Schlepper Ftmktion" 
or  conveyor was used by these early investigators to describe  the immuno- 
genicity enhancing action of the association of antigenic proteins with haptens. 
More recently, Plescia et al. (15) made use of this method to induce the forma- 
tion of antibodies in rabbits against nonantigenic or poorly antigenic macro- 
molecular  substances.  DNA,  and  pneumococcal polysaccharide  behaved  as 
haptens when allowed to form salt bridges with the positively charged antigen, 
methylated bovine serum albumin. We have taken advantage of the  strong 
positive charge of hapten PLL molecules at neutral pH to allow them to react 
similarly with negatively charged foreign and guinea pig serum albumins, in 
order  to  investigate  their  behavior  as  macromolecular  haptens  in  "nonre- 
sponder" guinea pigs and to study the immunological specificity of the anti- 
bodies produced. 
To obtain background data, immunizations with hapten-polyamino acid con- 
jugates without the use of adjuvants,  and with  adjuvants containing Myco- 
bacteria tuberculosis substituted  for  Mycobacteria butyricum,  were  also  per- 
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Materials and Methods 
Polypeptides and Proteins.--Two poly-L-lysine (PLL) hydrobromide preparations of aver- 
age molecular weight of 50,000  and 90,000  respectively and poly-D-lysine  (PDL)  hydrobro- 
mide of an average molecular weight of 23,000 were obtained from Pilot Chemical Co., Water- 
town, Massachusetts. 
Bovine serum albumin  (BSA), and  bovine fibrinogen (BF)  were obtained from Armour 
Pharmaceutical Co., Chicago. Twice recrystallized hen ovalbumin  (Ova) was obtained  from 
Pentex, Inc., Kankakee, Illinois; human serum albumin  (HSA) was purchased from Merck, 
Sharpe, and Dohme, Philadelphia. Guinea pig serum albumin (GPA) was prepared by starch 
block electrophoresis (16). Acetylated BSA was the gift of Dr. Paul Maurer, New Jersey Col- 
lege of Medicine and Dentistry. 
Polyanions.--Carboxymethylcellnlose  and polystyrene sulfonate were the gift of Dr. Max 
Shubert, New York University School of Medicine. Hyaluronic acid and dextran sulfate (molec- 
ular weight: 37,000 to 43,000) were obtained from Nutritional Biochemicals Corp., Cleveland. 
Highly polymerized deoxyribonucleic add (DNA) was purchased from Mann Research Labo- 
ratories, New York, and heparin sodium (10 mg/ml) from Vitarine Co., Inc., New York. 
Other Reagents.--Dried,  killed Mycobacteria tuberculosis hominis was the gift of Dr. Byron 
Waksman,  Yale University School of Medicine. Incomplete and  complete  (containing M. 
butyricum) Freund's adjuvants were obtained from Difco Laboratories, Detroit. Kaolin was 
purchased from Mallinckrodt Chemicaa Works, St. Louis. 
1-fluoro-2,4-dinitrobenzene  (DNFB)  was  obtained  from  Eastman  Organic  Chemicals, 
Rochester, New York. DNFB-SH (156 mc/mmole) was obtained from Nuclear-Chicago Corp., 
Chicago; 1-chioro-2,4Minitrobenzene-SH (DNCB-SH)  (19.5 mc/mmole)  was  obtained from 
New England Nuclear Corporation, Boston. N, ¢-2,4-dinitrophenyl-L-lysine (~-DNP-L-lysine) 
was  purchased  from  Cyclo  Chemicals,  Los  Angeles.  2,4-dinitrophenol  (DNP-OH,  Fisher 
Scientific Co.,  New  York)  was  recrystallized  once from  hot  water.  ¢-Aminocaproic acid 
(EACA) and earbobenzoxy (CBZ) chlorid  e were purchased from Mann Research Laboratories. 
Preparation of Conjugates.--DNP-PLL  was prepared by reacting PLL with DNFB under 
alkafine conditions as described previously (1). The synthesis of DNP-PDL by the reaction of 
PDL and DNFB was carried out at pH 7.6 in order to minimize the possibility of racemization 
of i)-lysine  residues.  DNP-PDL was freed of any unreaeted  DNFB by exhaustive dialysis, 
lyophilizatien, and acetone washing. DNP-GPA was prepared under alkaline conditions utiliz- 
ing  DNFB  as  previously  described  (17).  Polypeptide  or  protein  concentrations  were 
determined from miero-Kjeldahl nitrogen measurements; the degree of DNP substitution was 
calculated from absorbaney at 360 m/z on the basis of the molar extinction coefficient of free 
¢-DNP-l.-lysine [E 360  m/z  =  17,400 (18)]. The following DNP  conjugates were  prepared: 
DNP0.6-PLL240  (used  only  for  fuorescence  studies),  DNPn-PLLs40,  DNP14-PLL~4o, 
DNPs.5-PDL100, DNP41-GPA. Subscripts refer to the average number  of groups per  mole- 
cule of polypeptide or protein. 
Arsanilic acid azo-GPA (ASGPA) was prepared according to methods previously described 
(19). Acetylated GPA was prepared by reacting GPA with an excess of acetic anhydride at pH 
10. 
Carbobenzoxy-PLL was prepared by reacting carbobenzoxy chloride with PLL at pH 10; 
any unreacted material was removed by dialysis. 
DNp-SH-EACA was prepared by the reaction of EACA in 0.01 N NaOH with DNFB-SH 
(dissolved in benzene) or DNCB-SH (dissolved in dioxane). Reactants were mixed in the ratio 
1 mole DNP:8 moles EACA. The reaction was allowed to proceed overnight at room tempera- 
ture with constant stirring and the product was acid precipitated four times. DNP-SH-EACA 
prepared with DNCB-SH was recrystallized from slightly acidified water. 862  HAPTEN--POLY- L-L¥SINE  CONJUGATES 
Preparation of DNP-PLL. Conveyor Complexes.--Equimolar  amounts of BSA, HSA, GPA, 
and Ova were added to DNP-PLL in 0.075 M NaC1.0.1 N NaOH was then added dropwlse 
until a precipitate formed (20). 
Acetylated BSA and acetylated GPA were added to DNP-PLL or to DNP-PDL in equal 
weight amounts; no alkali was added. 
Polyanions were dissolved in saline and added to the DNP-PLL in the amounts shown in 
Table VI. 
Immunization.--Male and female Hartley strain guinea pigs weighing 300 to 400 g were 
purchased from Camm Research Inc., Wayne, New Jersey.  Strain 13 guinea pigs were  ob- 
tained from the Laboratory of Immunology, National Institute of Allergy and Infectious Dis- 
eases, Bethesda, Maryland. 
The basic immunization procedure consisted of the injection of 0.4 ml of an emulsion of 
equal parts DNP-polylysine (mol wt 50,000)  in 0.15 ~s saline and complete Freund's adjuvant 
(M. butyricum) into the four foot-pads. The total dose was 100 ttg. Guinea pigs were tested 
twice with 10/zg DNP-PLL injected intradermally in 0.1 ml during the 2 wk after initial im- 
munization. They were bled between days 21 and 25. 
In order to determine if adjuvants were required to obtain an immune response to DNP- 
PLL, guinea pigs received intraperitoneal injections of 2 mg of DNP-PLL in 0.15 M NaC1 and 
front foot-pad injections of 500 gg of DNP-PLL in saline. The animals received 100 #g injections 
of  DNP-PLL  in  saline in  each of 4  skin sites at 7 and at 14 days and were bled at 18 to 23 
days. They were then injected with 100 #g DNP-PLL in complete adjuvant (M. butyricum) as 
described in the basic schedule. 
The effect of substitution of M. tuberculosis for M. butyricum in adjuvant was studied by 
immunizing a group of guinea pigs according to the basic schedule with the exception that M. 
tuberculosis in incomplete Freund's adjuvant  (2 mg/mi) was used instead of the usual com- 
plete Freund's adjuvant (M. butyrieum). 
Finally, immunization with DNP-PLL bound to various conveyor molecules (both protein 
and polyanion) was carried out according to the basic schedule except that booster doses were 
60 to 100 ptg DNP-PLL. conveyor in addition to the 10 gg of DNP-PLL usually employed. 
Immunization  with Unconjugated PLL.--The determination of an immune response to PLL 
has proven to be a  difficult problem because of the large positive charge of this molecule at 
neutral pH. Thus nonspecific precipitation with many serum proteins (3, 20) often occurs and 
anaphylactic reactions may be affected by interaction of PLL with tissue components. How- 
ever, intradermal injections of 10 #g or less cause only slight nonspecific inflammatory skin 
reactions. Thus, immunization of 29 guinea pigs with 100/~g PLL emulsified in incomplete ad- 
juvant with M. tuberculosis (2 mg/ml) was performed and skin reactivity tested at 9 and 16 
days with 10 gg PLL injected intradermally. The guinea pigs were then immunized intra- 
dermally and intraperitoneally with 100 gg  DNP-PLL emulsified in complete adjuvant (M. 
butyr¢cum) and skin tested with 10 ptg DNP-PLL 1 and 2 wk subsequently. All animals were 
then bled. 
Assay of tke Immune Response to DNP-PLL Conjugates.--The  assay of the immune response 
of guinea pigs to H-PLL in previous studies (1, 2, 4, 7) has relied on precipitin reactions where 
they could be demonstrated or on various types of hypersensitivity reactions: delayed hyper- 
sensitivity, systemic anaphylaxis, and passive cutaneous anaphylaxis (PCA). Delayed hyper- 
sensitivity reactions have generally been found to be the most reliable test of an immune 
response to H-PLL in adjuvant immunized animals. Considering that these various methods 
may measure only certain classes of antibody, (systemic anaphylaxis and PCA only 'yl-anti- 
bodies (21)), a comparison of various antibody assays was made in the DNP-PLL system. It 
was observed that certain sera in which anti-DNP antibodies were demonstrable by gel diffu- 
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animals whose sera gave DNP-specific precipitin lines in gel developed only mild, or no sys- 
temic anaphylaxis when challenged with 250 #g DNP-GPA intravenously. The failure of ana- 
phylactic reactions to measure antibody demonstrable by precipitin methods could be ex- 
plained by the expected low levels of "rt-, and high levels of 72-antibodies produced by guinea 
pigs in the early stages of immunization with antigen in complete adjuvant (22). 
Some anti-DNP-PLL sera which produced specific precipitin lines with DNP-GPA failed 
to agglutinate DNP-GPA coated tanned  sheep  erythrocytes; anti-DNP-BGG sera in high 
dilution caused satisfactory agglutination of the same cell pretmmtions. Such findings empha- 
size that various assays of serum antibody which involve reactions subsequent to simple bind- 
ing of antibody to antigen may be unreliable when one is attempting to demonstrate the ability 
or inability to make an immune response to a given antigen. In order to a  old possible ambigui- 
ties of this sort, simple measurements of antigen binding by antibody  zere employed in the 
current study. Equilibrium dialysis was chosen as an unequivocal method for making these 
measurements. Three criteria were therefore used for evidence of an immune resFonse t ~ DN-P- 
PLL in guinea pigs injected with the antigen in complete adjuvants:  delayed reac ions to 
DNP-PLL, double diffusion in agar gel with DNP-GPA, and equilibrium dialysis. 
Delayed hypersensitivity of guinea pigs was determined by skin reaction 24 hr after intra- 
dermal injection of 10 #g of hapten-polylysine. Double diffusion  in agar gel was  performed 
utilizing commercially prepared agar plates (Immunoplates, pattern c, Hyland Laboratories 
Los Angeles). DNPa-GPA, 250 #g/ml, was placed in central wells and antis ira in peripheral 
wells. PCA (23),  systemic anaphylaxis  (24),  and hemagglutination of DNP GPA sensitized, 
tanned sheep erythrocy-tes  (25) were performed according to the techniques cited. 
Ealuillbrium Di~ysis.--(26)  of globulin fractions of antisera against  DNP-SH-EACA was 
performed utilizing washed Visking dialysis tubing and  glass test tubes.  Globulin fractions 
were precipitated 2X from 33% saturated  (NH4)2SO~  and dissolved in 0.15 x~NaC1, 0.01 M 
PO4, pH 7.2 (PBS) in a volume 5 times the original serum volume. They were then extensively 
dialyzed against PBS in the cold. 1 mi of globulin preparation was placed inside the dialysis 
sac and 0.9 ml of DNP-SH.EACA in PBS outside of the sac. Tubes were sealed and rotated 
for 18 hr at room temperature. Volume changes within the sac were determined by difference 
in weights of the dialysis bags before and after dialysis. 0.5 nd samples from inside and outside 
the sac were placed in 15 ml of Bray's solution (27) and counted in a Tricarb liquid scintillation 
counter  (Packard  Instrument  Co., La Grange, Illinois). Bound hapten was calculated from 
the expression: 
Bound hapten _  5 (counts inside sac -- counts outside sac)  X  (volume inside sac)/0.5  ml 
m~/mi  Specific  activity  (counts/n~) 
Where small amounts of antibody were expected, DNP-aH-EACA at 2 X  10  -~ •  was used; 
when large amounts of antibody were anticipated, a hapten concentration of 5 X  10  -0 g  was 
used. The values obtained measure total antibody when small amounts of antibody were pres- 
ent; however, when large amounts of antibody were present, there was insufficient  hapten to 
occupy all sites and thus a  minimum estimate of antibody content is obtained in such cases. 
In each group of equilibrium dialyses, the globulin fraction from the serum of a normal 8ninea 
pig and a buffer control were run. The globulin fraction from each experimental animal was 
analyzed separately. 
Globulin fractions from the sera of 41 guinea pigs immunized with complete adjuvant a one, 
unconjugated PLL, or BSA in complete adjuvants were subjected to equilibrium dialysis to 
obtain values for nonspecific binding. The mean was 240 X  10  -1° mxr/ml serum with a  stand- 
ard deviation of 205 X  10-1°. Values which were in excess of 650 X  10-1° m~/ml  (+  2  sD) 
were considered to demonstrate specific binding by antibody (Table II). Considering the large 864  ]~APTE  N--POLY-  L-LYS  INE CONJUGATES 
amount of data, only mean values for each group have been tabulated. In each instance in 
which only  some animals  in  a group showed serum antibody by equilibrium  dialysis  the  num- 
ber of  such animals  is  indicated. 
Purification o/Anti-DNP Antlbody.--Anti-DNP  antibodies were specifically purified  ac- 
cording to the methods of Farah et al. (28). Antibody was precipitated from sera, in the pres- 
ence  of  0.01 ~s  disodiumethylenediaminetetraacetate, by equivalence amounts of DNP-BF. 
It was specifically eluted with 0.1 ~r DNPOH;  DNP-BF was removed by precipitation with 
streptomycin sulfate (35 mg/ml). DNPOH was removed by dialysis against PBS followed by 
chromatography with Dowex  l-X8 (200 to 400 mesh). Purified antibody preparations were 
essentially free of  DiNPOH  and were shown by immunoeleetrophoresis against rabbit anti- 
whole guinea pig sol  an to contain only ~/1- and q/2-globulins. 
Immunological S~ ecificity of Anti-DNP-PLL Antibodies.--To  evaluate the specificity of 
anti-DNP antibodies produced in these experiments, titrations of the quenching of the native 
fluores :ence o¢ antibody by hapten were performed according to the technique of Velick et al. 
(29). ~ tuoresc race at approximately 350 m# of antibody excited at 280 m# was measured in a 
thermostated Aminco-Bowman spectrophotofluorometer at 26°C.  Duplicate 2.0 ml samples of 
spedfically purified anti-DNP antibody at a concentration of 30 #g/ml in PBS, pH 7.6, were 
titrated with e-DNP-I,-lysine and with DNP0.6-PLL240 as described previously (9,  10). This 
DNP-PLL conjugate was shown in previous studies to be suitable for this type of measure- 
ment (9). The c egree of quenching of antibody fluorescence by these two ligands was compared 
in terms of the xmount of DNP groups added. 
Average intrinsic association constants (K0) were calculated from fluorescence quenching 
data according to the Sips equation (30, 31): log r/(n -- r)  =  a log c +  a log K0, where r is 
antibody sites bound/antibody molecules, c is concentration of free hapten, and a is Sips hetero- 
geneity index. K0's determined from fluorescence quenching titrations of guinea pig anti-DNP 
antibodies have been demonstrated to be accurate as shown by comparison with equilibrium 
dialysis. Similar results were obtained with the two methods when a  value for maximum pos- 
sible quenching of antibody fluorescence of 100% was used (10). 
~S~TS 
Immune Response of Guinea Pigs to DNP-PLL with and without Adjuvants.-- 
Immunization of guinea pigs with DNP-PLL in saline gave  the following re- 
sults: Of a total of 34 animals, 10 produced circulating anti-DNP antibodies as 
judged by the results of double diffusion analysis in agar and PCA studies. The 
sera of the rest of the animals were entirely negative. The animals were then re- 
immunized with DNP-PLL with complete adjuvant containing M. butyricum. 
With one exception, the same animals that produced antibody now gave delayed 
reactions  to the immunizing  antigen. One animal that had initially produced 
antibody failed to give a delayed reaction (Table I). 
In the past all guinea pigs not developing delayed sensitivity to DNP-PLL 
had not produced any anti-DNP antibody as judged by the techniques utilized. 
In order  to more firmly establish  that non-skin reactor guinea pigs  did not 
produce  any anti-DNP antibody, 13 guinea pigs were immunized with DNP- 
PLL in the usual fashion with complete adjuvant (M. butyricum).  Six of these 
13 animals responded by developing delayed sensitivity and by producing circu- 
lating antibody. The other 7 animals failed to develop a delayed skin reaction IRA  GREEN~  WILLIAM  ]~.  PAUL,  AND  BARUJ  BENACERRAF  865 
and did not produce any anti-DNP antibody as judged by equilibrium dialysis 
(Table II), thus confirming the results of previous studies. 
Next, the effect of substitution  of Mycobacterium  tuberculosis  for Mycobac- 
terium  butyricum  in  the  adjuvant was  tested.  Twenty guinea pigs  were im- 
munized with DNP-PLL and incomplete Difco adjuvant containing 2 mg/ml 
of dried M. tuberculosis.  Fourteen of these animals made an immune response as 
demonstrated by the development of delayed sensitivity and the production of 
circulating antibody (Table II). Because the percentage of positive animals was 
higher than usually observed in random bred guinea pigs, the following experi- 
ments were performed: (a) Animals were immunized in the usual fashion with 
DNP-PLL in complete adjuvant (M. butyricum).  Ten nonresponding animals 
TABLE I 
Antibody Production and Ddayed Hypersensitivity Reactions of Guinea Pigs Immunized First 
with DNP-PLL in Saline and Then with DNP-PLL in Adjuvant 
First immunizing  antigen 
3 mg DNP-PLL in 
saline 
No. 
animals 
34 
Gel diffu- 
sion* 
No. pos./ 
lotal 
1o§/34 
PCA~ 
No. t~os, 
total 
10§/3, 
Second immunizing antigen 
100/~g DNP-PLL in adjuvant 
containing M.  bulyricum 
Delayed 
reactions to 
9§/3~.~ 
* 250/zg/ml DNP41-GPA. 
Positive in titers of 1:40 to 1:160 with 250 #g DNP4rGPA. 
§ These are the same animals; one of these animals that produced antibodies later failed 
to show a delayed response to DNP-PLL. 
were selected and were subsequently reimmunized with  100 #g DNP-PLL in 
adjuvant  in  which  M.  tuberculosis  2  mg/ml  was  substituted  for  the  M. 
butyricum. These previously negative animals were then retested. They did not 
become positive.  (b)  Another group  of 10  guinea  pigs  was  immunized with 
DNP-PLL without adjuvant according to the schedule previously described. 
Two of these animals made circulating antibodies as detected by gel diffusion 
and PCA. The other 8 animals did not produce antibodies. All the animals were 
then immunized with  100/zg DNP-PLL in adjuvant containing 2 mg/ml M. 
tuberculosis.  The animals were subsequently skin tested with 10 #g DNP-PLL; 
only the 2 animals that had previously responded showed delayed reactions to 
DNP-PLL. The remainder of the animals were negative. The substitution in 
the adjuvant used for immunization of M. tuberculosis  for M. butyricum does 
not convert previously DNP-PLL nonresponding animals  to responding ani- 
mals. The somewhat higher percentage of positive animals obtained in the ini- 
tial experiment using DNP-PLL in adjuvant containing M.  tuberculosis  was 866  HAPTEN--POLY-  L-LYS  IN-E  CONJUGATES 
apparently due to the fortuitous presence of a larger number of reactors in this 
group. 
Animals immunized with DNP-PDL and complete adjuvant containing M. 
butyricum did not develop delayed sensitivity or produce circulating antibodies, 
TABLE II 
Delayed Sensitivity to DNP-PLL and Serum Level of Anti-DNP Antibodies in 
Animals Immunized with DNP-PLL or DNP-PDL with Adjuvants Containing 
M. Butyricum or M. Tuberculosis 
Immunizing antigen 
Equilibrium dialysis 
DNP-EACA 
(2 X  10-7 M)  E•uilibrium  ialysis 
DNP-EACA 
(5 X  10-e u) 
mM Hapten bound/cc of serum 
×10-t0~ 
100pg DNP-PLL in ad-  6508§ 
juvant containing  M.  370 
bvJyrlcura 
100 #g DNP-PLL in ad-  5942 
juvant containing M.  450]] 
~ubemulosis 
100paDNP-PDLinad- 
juvant containing M. 
buiyrlcum 
100pgDNP-PDLinad- 
juvant containing M. 
tuberculosis 
Control  Group 
100 p~g PLL in adjuvant 
Adjuvant in saline 
10 ~+g BSA in adjuvant 
Total  .................... 
195 
366 
Average for 41 Animals 
240 
+I Standard deviation =  445 
+2 Standard deviation ffi 650 
36,691  (s)§ 
* 250 pg/ml DNP41-GPA. 
~t 7.5 pg of antibody can bind 1000 X 10  -1° nm of hapten when both sites are occupied considering  150,000  tool 
wt for guinea pig antibody. 
§ This figure represents an average value. The number in parentheses is the number of individual animals 
tested when all animals were not tested. 
Jl One individual value fell outside of 2 standard deviations from the mean of the control animals. 
confirming the lack of antigenicity of hapten-PDL conjugates (32, 33)  (Table 
II). 
Antigenicity of PLL.--Fourteen out of 29 guinea pigs immunized with PLL in 
complete adjuvant with M. tuberculosis showed delayed hypersensitivity reac- 
tions to 10 #g of PLL, when tested at 2 and 3 wk after immunization. The re- 
actions were mildly indurated and ranged from about 7 to 12 mm in diameter 
(Table III). To control for the presence of an unknown impurity in the PLL IRA  GREEN,  WILLIAM E.  PAUL,  AND  BARUJ  BENACERRAF  867 
preparation used for immunization the animals were also tested with another 
PLL  with different average  molecular  weight (90,000) with ~dentical results. 
Similar  reactions  were also obtained with a  PLLI~-3o preparation synthesized 
by Dr.  Stuart Schlossman,  Harvard Medical School,  the polymerization of 
which had been initiated with NAOH. A haptenic material possibly associated 
with PLL which might account for these results is the carbobenzoxy  (CBZ) 
group.  PLL  is synthesized by the manufacturer according  to the method of 
Katchalski (34) which involves blocking the e-amino group of the N-carboxy 
anhydride of lysine with carbobenzoxy  chloride prior to polymerization. The 
CBZ groups are split off after polymerization and the preparation is believed to 
TABLE III 
Delayed ~ensitivity to PLL and DNP-PLL, and ,Serum Levels of Anti-DNP 
Antibodies in Animals Immunized First with PLL and Then with DNP-PLL 
First immunizing 
antigen 
100 pg PLL in adjuvant 
containing  M.  lubsr- 
culosis 
No. 
mimals 
29 
Delayed 
reaction 
to PLL 
10 pg 
Second immunizing 
antigen 
100 pg  DNP-PLL  in 
adjuvant containing 
M. butyricum 
No. of responder 
animals as judged  Gel 
by delayed reac-  Diffu- 
tions to DNP-PLL  sion* 
I0  pg 
No. hos./ 
tota 
Responders  14§  14/14 
Nonresponders  15§  0/15 
Equilibrium 
dialysis  e 
DNP-EACA 
mJ~ Hapten 
bound/cc of 
~erum  X 10  -1' 
(2 ×  10-7 M: 
139 
* 250 pg/rnl DNP,I-GPA. 
7.5 pg of antibody can bind 1000 X 10-z0  mM of hapten when both sites are occupied  considering  150,000 tool 
wt for guinea pig antibody. 
§ These are the same animals that showed a delayed reaction or failed to show a delayed reaction to PLL alone 
be free of conjugated CBZ. The possibility had to be considered that the PLL 
preparation used for immunization contained traces of CBZ-PLL and that the 
delayed reactions observed to PLL could in fact be the result of immunization 
and testing with CBZ-PLL. In order to test this, CBZ-PLL were prepared by 
the reaction of CBZ chloride with PLL hydrobromide. PLL-sensitized guinea 
pigs were tested with 10 #g intraderrnal injections of PLL and of CBZ-PLL. The 
reactions  to both products were identical in size and intensity. No delayed 
reactivity attributable to CBZ could be demonstrated as the relatively highly 
conjugated CBZ-PLL would have been expected to give a considerably  more 
intense delayed reaction than PLL possibly containing traces of CBZ. Rather, 
the  results  indicate  that  the  immune  response was to PLL. No antibodies 
specific for PLL or for CBZ-GPA could be detected by active cutaneous ana- 
phylaxis in the PLL responder  guinea pigs. 
Considering  the relative mildness of the delayed reactions  to PLL and the 
known irritating properties  of PLL, it was felt that the evidence of an immune 
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action to this homopolymer were the same animals genetically capable of pro- 
ducing antibodies  to DNP-PLL. Indeed when all the PLL immunized guinea 
pigs were reimmunized with DNP-PLL in adjuvants the same 14 positive guinea 
pigs produced anti-DNP antibodies. The 15 animals which had not shown de- 
layed reactions  to PLL failed  to show delayed reactions  to DNP-PLL or  to 
produce anfi-DNP antibodies detectable by equilibrium dialysis and were con- 
sidered nonresponders  (Table III). 
The Effect of Interaction with Foreign and Homologous Serum Albumin on the 
Immune Response to DNP-PLL and DNP-PDL.--When foreign serum albu- 
mins (BSA, acetylated BSA, HSA, or ovalbumin) were allowed to interact with 
DNP-PLL to form electrostatic  complexes and the animals  were immunized 
with such preparations in complete adjuvant, a new pattern of immune response 
to DNP-PLL was observed. The usual percentage of Harfley strain guinea pigs 
(30 to 40 %) became delayed  hypersensitive  to DNP-PLL but all the animals, in- 
cluding the ones without delayed hypersensitivity  to DNP-PLL, produced a con- 
siderable  amount of antibody against the dinitrophenyl hapten, ranging from 
about 170 to 830/~g of antibody/ml  as estimated  by  equilibrium dialysis measure- 
ments (Table IV). No significant differences could be noted between the amounts 
of anti-DNP antibody produced by the guinea pigs with and without delayed  re- 
actions  to DNP-PLL. Four strain 13  ("genetic nonresponders")  guinea pigs 
immunized with DNP-PLL. BSA in complete adjuvants also made significant 
amounts of anti-DNP  antibodies  as  measured  by equilibrium  dialysis  with 
DNP-3H-EACA and showed absence of delayed hypersensitivity to DNP-PLL. 
All guinea pigs also showed strong delayed reactions  to the foreign albumins 
used for immunization. These findings are in distinct contrast with all previous 
results of immunization with DNP-PLL in complete adjuvants without foreign 
albumins (1, 2) (Tables II, VI). In the previous experiments there was always a 
complete  correlation  between  the development of delayed hypersensitivity to 
H-PLL conjugates  and the production of antihapten antibodies  in responder 
guinea pigs. Thus, immunization with DNP-PLL bound to foreign albumins by 
electrostatic forces can induce nouresponder  guinea pigs to produce  anti-DNP 
antibodies but cannot render  them "complete responders,"  since they cannot 
show delayed reactions  to the H-PLL conjugates.  These  experiments  demon- 
strate that DNP-PLL which is a complete antigen in "responders" can behave 
as a hapten in nonresponder  guinea pigs. 
A similar pattern of immune response is observed in guinea pigs immunized 
with DNP-PLL mixed with guinea pig albumin, or with guinea pig albumin con- 
jugated with acetyl or benzarsonate groups,  but the level of anti-DNP anti- 
bodies produced was very much lower, especially in animals immunized with 
DNP-PLL. GPA (Table IV),  and could  only be detected by equilibrium  di- 
alysis.  Furthermore not  all  animals  immunized with  DNP-PLL  bound  to 
guinea pig albumin produced anti-DNP  antibodies.  The sera of 4 out of 12 IRA  GREEN~  WILLIAM  E.  PAITL, AND  BARU~ BENACERRA.F  869 
TABLE IV 
The Effect of Various Albumins  Combined with DNP-PLL on the Production of Anti-DNP~ 
Antibodies by Responder and Nonresponder Guinea Pigs 
Immunizing  antigen*  No.  animals 
100 #g DNP-PLL com- 
bined ~ 100 #g acet. 
BSA 
100 #g DNP-PLL com- 
bined ~ 120/~g BSA 
100 #g DNP-PLL com- 
bined ~ 120 #g HSA 
100/~g DNP-PLL com- 
bined ~  80  k~g  ovalbu- 
rain 
100 gg DNP-PLL  com- 
bined ~ 120 #g GPA 
100 gg DNP-PLL com- 
bined ~: 100 #g arsa- 
nilic-GPA 
100 gg DNP-PLL com- 
bined ~ 100 #g acet. 
GPA 
Equilibrium  Equilibrium 
dialysis e  ] dialysis e DNP- 
No. of responder animals  DNP-EACA  EACA 
as juc~ed by delayed  Get diffu- (2 X  10  -7 M)  (5 X  10  TM M) 
reactions to DNP-  sion~ 
PLL 1o #g 
32  Responders  10 
Nonresponders  22 
No. lJos./ 
total 
lO/lO 
22/22 
39  Responders  10  10/10 
Nonresponders  29  29/29 
Responders  3  3/3 
Nonresponders  6  6/6 
10  Responders  6  6/6 
Nonresponders  4  4/4 
Responders  4  4/4  7041H 
Nonresponders  12  0/12  978¶ 
16 
16  Responders  6  6/6  8179 
Nonresponders  10  1/10  1182"* 
Responders  2  2/2  7150 
Nonresponders  10  2/10  2308~$ 
mu ]~pten Bound/cc of 
Serum X  10-1°§ 
12 
88,389 (4)[] 
111,508  (5) 
97,890  (4), 
67,173  (9) 
52,228 
i  23,041 
I  76,135 
54,124 
* Adjuvant containing M. butyricum used with these antigens. 
:~ 250 #g/ml DNP4rGPA. 
§ 7.5 #g of antibody can bind 1000 X  10  -1° m~ of hapten when both sites are occupied 
considering 150,000 tool wt for guinea pig antibody. 
11 This figure represents an average value. The number in parenthesis is the number of 
individual animals tested when all animals were not tested. 
¶ Four individual  values  outside  of  2  standard  deviations  from  mean  of  the  control 
animals (see Table I). 
** Eight individual values under 2 standard deviations from mean of the control animals 
(see Table I). 
:~:~ 2 individual values under 2 standard deviations from mean of the control animals. 870  HAPTEN--POLY- L-LYSINE  CONJUGATES 
nonresponder animals immunized with DNP-PLL. GPA, 2 out of 10 immunized 
with DNP-PLL. AS-GPA and 8 out of 10 immunized with DNP-PLL- acetyl- 
GPA  showed  hapten-binding  values  outside  of  2  standard  deviations  from 
the mean of control animals (Table IV). 
Immunization with DNP-PDL associated with acetylated BSA also induced 
the formation of anfi-DNP antibodies in guinea pigs; no delayed hypersensi- 
tivity was observed to DNP-PDL. However, the level of anti-DNP antibodies 
in the sera of these animals was just at the limit that could be considered sig- 
nificant, by equilibrium dialysis measurements (see Table V). Guinea pigs ira- 
TABLE  V 
The Effect of BSA and Acetylated BSA  Combined with DNP-PDL  on the 
Production of Anti-DNP Antibodies 
Immunizing  antigen 
100/zg DNP-PDL combined ~ 120/zg BSA 
100/zg DNP-PDL combined ~ 100 #g acet. BSA 
L~]'O. 
animals 
18 
6 
Delayed 
reaction 
to DNP- 
PDL 10 t~g 
o/18 
o/6 
Gel diffu- 
sion* 
0/18 
0/6 
Equilibrium 
dialysis ~ DNP- 
EACA 
(2 X 10  -7 ~) 
mu Hapten 
bound/co of 
serum ×  10-ao~ 
484§ 
67811 
* 250 #g/ml DNP41-GPA. 
7.5 lzg of antibody can bind 1000 X  10  -1° m~ of hapten when both sites are occupied 
considering 150,000 tool wt for guinea pig antibody. 
§ These figures represent average values of the number of animals shown in each group. 
I[ The values from 3 sera fell above 2 standard deviations from the mean of the control 
(see Table I). 
munized with DNP-PDL mixed with BSA did not produce significant amounts 
of anti-DNP antibodies (Table V). 
Considering  that  albumins  used  as  conveyor molecules  for  DNP-PLL  in 
these experiments reacted with DNP-PLL to form insoluble complexes, control 
experiments were  carried  out  investigating  the  result  of immunization  with 
DNP-PLL precipitated  by various nonantigenic  macromolecular polyanionic 
polymers: DNA, dextran sulfate, heparin, carboxymethylcellulose, polystyrene, 
and hyaluronic acid. The results of these experiments axe presented in Table VI. 
Irrespective of the polymer used only the usual 30 to 40 % of guinea pigs gave 
an immune response to DNP-PLL and there was again a complete correlation 
between  delayed hypersensitivity to DNP-PLL and  the production  of  anti- 
DNP  antibodies by responder guinea pigs.  The sera  of nonresponder  guinea 
pigs  showed  hapten-binding  values  comparable  to  those  observed  in  non- 
immunized  control  animals,  demonstrating  the  absence  of  anti-DNP  anti- 
bodies in these animals. IRA  GREEN, WILLIAM E. PAUL~ AND  BARUJ BENACERRAF  871 
PLL Specificity  of Anti-DNP Antibodies  Produced by Nonresponder Guinea 
Pigs Immunized with DNP-PLL Comple~d with Foreign Albumins as Conveyors. 
--Studies of the immunological specificity of anti-DNP-PLL antibodies pro- 
TABLE VI 
The Effect of Various Polyanions Combined witk DNP-PLL on tie Production of Anti-DNP 
Antibodies by Respo~er and Nonresponder Guinea Pigs 
Immunizing  antigen* 
100 #g DNP-PLL  combined ~ 200 #g 
dextran sulfate 
100 #g DNP-PLL combined ~ 2 mg 
heparin 
190 #g DNP-PLL combined ~ 1 mg 
DNA 
100 #g DNP-PLL combined ~ 100 #g 
polystyrene sulfonate 
100/~g DNP-PLL combined ~ 100 #g 
carboxymethyl cellulose 
100 #g DNP-PLL combined ~: 200 #g 
hyaluronic acid 
100 pg DNP-PLL combined ~ 2 mg 
Kaolin 
No. of responder animals 
No.  as judged  bydelayed 
mimals  reactions  to DNP-PLL 
lO  ~g 
Responders  2 
Nonresponders  3 
Responders  1 
Nonresponders  4 
Responders  1 
Nonresponders  4 
Responders  2 
Nonresponders  2 
Responders  2 
Nonresponders  3 
Responders  2 
Nonresponders  3 
Responders  3 
Nonresponders  2 
Gel Di 
sion: 
No. ~o 
totu~ 
2/2 
0/3 
1/1 
0/4 
1/1 
o/4 
2/2 
0/2 
2/2 
0/3 
2/2 
0/3 
3/3 
0/2 
Equilibrium 
dialysis ~  DNP- 
EACA 
(2 X 10-~ ~,) 
mu Hapten 
bou~/c~  of  serum X lO'~O§ 
3v.oH 
122 
Not done 
Not done 
4380 
182 
3428 
107 
6389 
192 
3917 
366 
6041 
122 
* Adjuvant containing  M. butyr~um used with these antigens. 
:~ 250 #g/ml DNP41-GPA. 
§ 7.5 #g of antibody can bind I000 X  10  -1° mM hapten when both  sites are occupied 
considering 150,000 tool wt for guinea pig antibody. 
I] This figure represents an average value of the number  of animals shown in the responder 
and nonresponder groups. 
duced by responder guinea pigs were made (9) utilizing the technique of fluores- 
cence quenching. Immunological specificity of anti-DNP-PLL antibodies for 
the  PLL  carrier was demonstrated by a  higher K0 of  these  antibodies with 
DNP0.6-PLI~0 than with e-DNP-~-lysine. The free energy contribution of the 
PLL  carrier  to  the  interaction of  anti-DNP-PLL antibodies with  DNP0.e- 
PLI~0 was from --0.8 to --2.1 kcal/mole (9). This value should be viewed as a 
minimum  estimate of energy of carrier specificity contributed by the PLL mole- 872  HAPTEN--POLY- L-LYSINE  CONJUGATES 
cule because DNP0.e-PLL~0  which was used for fluorescence quenching meas- 
urements must be considered as highly cross-reactive with and not identical to 
the more highly substituted antigens used for immunization. In contrast, anti- 
DNP  antibodies  produced  by  guinea  pigs  immunized  with  DNP-BSA  and 
other  DNP-proteins  were  quenched  to  a  greater  degree  by e-DNP-L-lysine 
than by DNP0.e-PLL~0 (9). 
TABLE 'VII 
A~erage Intrinsic Association Co.rants (Ko) of Purified Anti-DNP Protein Antibodies and 
AntI-DNP-PLL Antibodies Prepared in Nonresponder Guinea Pigs 
Utilizing Conveyor Molecules 
Immunizing antigen 
DNP-PLL. Acet. BSA .......... 
DNP-PLL. Ova ............... 
DNP-PLL-HSA .............. 
DNP-PLL- BSA ............... 
DNP-PLL- BSA ............... 
DNP-PLL- BSA ............... 
DNP-PLL. B SA  ............... 
DNP-PLL$ ................... 
DNP-BSA§ ................... 
DNP-Ova§ ................... 
Identification 
No. 
Pool 4 
Pool 1A 
Pool 7 
123-5 
123-7 
123-8 
123-9 
Pool 1 
75 
66 
K0 X  10  -e 
DNPo.rPLL ~ 
liters~mole 
28. 
>100.* 
3.2 
>100.* 
35. 
48. 
27. 
24. 
0.059 
1.6 
KO X  10  TM 
*-DNP-L- 
lysine 
liters~mole 
3.0 
8.6 
0.71 
9.6 
4.1 
1.5 
3.0 
3.2 
0.80 
8.2 
K~-DNP-L- 
lysine 
9.3 
>11.6 
4.5 
>10.4 
8.5 
32.0 
9.0 
7.5 
0.074 
0.20 
* Fluorescence  quenching titrations of guinea 3  ng anti-DNP antibodies do not accurately 
measure K0's in excess of 10  s liters/mole. 
$ Anti-DNP-PLL antibodies were prepared in responder guinea pigs. Data is taken from 
reference 9. 
§ Anti-DNP-BSA and anti-DNP-Ova antibodies were prepared in Hartiey strain guinea 
pigs. Data from reference 9. 
These  observations on  carrier specificity of anti-DNP-PLL  and  anti-DNP 
protein antibodies made it  essential to  study as part of these experiments the 
specificity of anti-DNP antibodies produced by nonresponder guinea pigs im- 
munized  with  DNP-PLL  reacted with  foreign proteins  to  ascertain whether 
these antibodies also showed specificity for the PLL molecule or whether they 
differ in this respect from the anti-DNP-PLL antibodies produced by responder 
guinea pigs. 
Pooled,  specifically purified anti-DNP  antibodies from  animals immunized 
with  DNP-PLL  associated with  acetylated BSA,  HSA,  and  ovalbumin  were 
examined; in addition, purified antibodies from 4 individual animals immunized 
with DNP-PLL.BSA  were titrated. In all cases these antibodies were obtained IRA GREEN, WILLIAM E. PAUL, AND BARUJ BENACERRA~  8~3 
from guinea pigs without delayed hypersensitivity to DNP-PLL ("nonrespond- 
ers"). The results of these experiments are presented in Table VII and Fig. 1. 
The fluorescence of each of these antibody preparations was quenched to a 
greater degree by DNP0.6-PIJ-~0 than by ~-DNP-L-lysine, demonstrating their 
specificity for the PLL molecule. No difference could be detected in this respect 
between these antibodies and anfi-DNP-PLL antibodies produced by responder 
animals immunized with DNP-PLL without carrier proteins. 
GUINEA PIG 
ANTI -  DNP - PLL 
POOL  1 
10 
20 
30  L'LYSINE 
50  '  "  --  k 
0  60-- 
DNPo,6" PLL  240 
80-- 
90 m 
I  i  I  I  I  i 
0  02  04  0:6  08  10  12 
GUINEA PIG 
ANTI- DNP- PLL" BSA 
123 - 7 
10 
2O 
50  L-LYSINE 
60  --  "~. 
70  --  "/-- 
/ 
80  --  DNPo'e  - PLL  2  40 
90-- 
I  I  I  I  i  I 
0  02  04  06  08  10  12 
GUINEA PIG 
ANTI  DNP  OVALBUMIN 
POOL 66 
0 
10 
20 
50 
40 
50 
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70 
80 
90 
~k  DNPo6"PLL240 
C-DNP-L-LYSINE 
I  I  I  I  I  I 
0  0.2  0.4  0.6  0.8  1.0  1.2 
AMOUNT  OF  LIGAND  ADDED-m#  MOLES 
FIG. 1. Fluorescence  quenching  of anti-DNP antibodies  by e-DNP-L-lysine  and by DNP0.e 
PLL240 • Measurements  were carried out on 2 ml samples containing  30/~g purified  antibody/ 
ml in PBS at 26°C. Amounts  of ligands added are expressed in terms of DNP groups. 
DISCUSSION 
DNP-PLL, a complete antigen in genetic responder guinea pigs, behaves aS a 
hapten in nonresponder guinea pigs. Thus, guinea pigs genetically unable to 
recognize the antigeuicity of DNP-PLL nevertheless form anti-DNP antibodies 
when immunized with electrostatic aggregates of this positively charged con- 
jugate with several negatively charged albumins. In spite of making anti-DNP 
antibodies, such animals do not  show delayed hypersensitivity to DNP-PLL 
which is normally exMbited by genetic responder guinea pigs immunized with 
this antigen. That the protein carrier molecules do not play a passive role in 
these immunogenic complexes, is shown by the lack of antigenldty of complexes 
of DNP-PLL and nonprotein polyauions for genetic nonresponder animals. 874  HAPTEN--POLY- L-LYSINE  CONJUGATES 
The use of covalently bound protein carriers to induce the formation of anti- 
bodies  against haptenic determinants is  a  classical immunological  technique 
introduced by the pioneer  studies of Landsteiner (14). It has generally been 
assumed,  however,  that haptens are low molecular  weight compounds  which 
need to be bound to the protein carrier by covalent linkage. The production of 
anti-DNA antibodies by immunization with DNA complexed with methylated 
BSA (15), and the results  of our experiments  where positively charged DNP- 
PLL complexed with negatively charged foreign albumins stimulated the syn- 
thesis of antihapten antibodies demonstrate that haptens can be indeed of very 
large size and that the bonds between hapten and carrier molecule can be the 
result of electrostatic  interaction. Similar results  were reported by Maurer for 
an aggregate  of poly-L-glutamic acid and methylated BSA (35). Since the re- 
action of a carboxyl ion with an ionized amino group involves about 10 kcal of 
energy (36), several such interactions can provide an energy of binding equal to 
that of a covalent bond. 
Contrasting with the high level of anti-DNP antibodies  produced  by non- 
responder  guinea pigs immunized with DNP-PLL and foreign albumins,  ani- 
mals immunized with DNP-PDL and acetylated BSA produced barely detect- 
able levels of DNP antibodies showing that DNP-PLL and DNP-PDL are not 
equally immunogenic haptens. 
Landsteiner reported in his early studies  with an alcoholic extract of the 
Forssman hapten that only antigenic  proteins  could  act as  effective carriers 
while homologous proteins  could not. Similar results have been obtained with 
DNP-PLL in nonresponder guinea pigs; foreign albumins behave as much more 
efficient conveyors to induce the formation of anfi-DNP antibodies  than does 
guinea pig albumin or its benzarsonate  or acetyl conjugates. However, haptens 
covalenfly linked to nonimmunogenic autologous proteins are known to induce 
a  good  immune response  (17). More drastic  alterations in  the  structure  of 
nonimmunogenic  autologous  proteins  resulting  from  covalent  conjugation 
with the hapten may in part account for these differences. 
The concept of hapten introduced by Landsteiner has been a great stimulant 
to immunological thought, but it has had the consequence of focusing the con- 
cern of investigators  on the hapten and the carrier as distinct entities and dis- 
tinct antigenic determinants. When antihapten antibodies were investigated 
for carrier  specificity it became  apparent that their immunological specificity 
extended clearly to areas of the carrier molecule adjacent to the site of attach- 
ment of the hapten (9,  10,  37-39).  The antigenic  determinants able  to best 
react with the specific antibody and able  also to induce and boost  (40) the 
specific immune response in hapten-protein systems and in the H-PLL system 
includes both hapten and the covalently bound carrier molecule both of which 
can be considered as partial determinants supplying part of the required energy 
of interaction with the specific antibody. IRA  GREEN,  WILLIAM  E.  PAUL,  AND  BARUJ  BENACERRAF  875 
Thus, it is not surprising that poly-L-lysine was found to be weakly antigenic 
in guinea pigs able to respond to haptenic conjugates of the polymer. The im- 
mune response to PLL was only demonstrable by mild delayed hypersensitivity 
reactions; in guinea pigs immunized with weak antigens in complete adjuvants 
this is the most sensitive test as was shown in studies of antigenicity of de- 
natured autologous gamma globulin (41). The gene controlling the antigenicity 
of H-PLL conjugates in responder guinea pigs can be considered therefore to 
be the same gene necessary to form an immune response to poly-L-lysine al- 
though this does not allow as yet a definition of what is governed by this gene. 
The two alternative possibilities previously considered must be discussed: (a) 
a metabolic reaction on the PLL, prior to the recognition of specificity, pos- 
sibly in the macrophages, to form the specific inducer (this will be referred to 
as the "metabolic gene hypothesis"), and (b) the specific immunological recog- 
nition of PLL as a partial antigenic determinant because of the previous synthe- 
sis of a cellular antibody capable of reacting with it. This will be referred to as 
the "specificity gene hypothesis." 
If this last possibility is true, one needs also to postulate that a single gene 
may control only part of the immunological specificity of an  antibody to ac= 
count for the data obtained in the H-PLL system, where it has been shown that 
the ability to synthesize antibodies against different hapten conjugates of PLL 
is under control of the same gene (42). 
The "metabolic gene hypothesis" was initially proposed because PLL was 
believed not to be antigenic and it was observed that any hapten on PLL, as 
well as the copolymer of L-glutamic acid and L-lysine would stimulate antibody 
formation in genetic responder animals (1).  The results of these experiments 
however are more favorable to the "specificity gene" hypothesis because (a) 
PLL alone was shown to be capable of inducing an immune response in genetic 
responders,  and  (b)  the formation of anti-DNP  antibodies by nouresponder 
animals immunized with H-PLL complexes with negatively charged albumins 
is stimulated much more effectively with foreign albumin than with guinea 
pig albnmlu. This last observation suggests that it is not the presence of any 
individual L-amino acids in the carrier molecule but the presence of recognizable 
foreign protein  determinants which are  necessary for immunogenicity. This 
interpretation of the nature  of the genetic control of  the immune response 
against H-PLL antigens is analogous to that proposed for similar genetic data 
in mice with  other synthetic antigens,  copolymers of L-amino acids, whose 
antigenicity depends  also  upon  the  presence  of  single  dominant  autosomal 
genes (43, 44), or to that proposed to explain the recognition by strain 2 and 
strain  13  guinea pigs of different antigenic determinants on the beef insulin 
molecule  (45). 
A  most intriguing observation in  our  experiments was  that nonresponder 
guinea pigs immunized with DNP-PLL complexed with foreign albumins form 876  HAPTEN--POLY-  L-LYSINE CONJUGATES 
anti-DNP-PLL antibodies but do not show delayed hypersensitivity reactions 
to DNP-PLL. It would appear from these observations that the same proper- 
ties of the antigen are required to induce an immune response and  to elicit 
delayed reactions in sensitized animals, and that an operation  controlled by 
the same gene is involved at some stage in both reactions. 
A similar conclusion was reached by Schlossman et al. (46) in the course of 
their  studies of the minimum size of a,N-DNP-oligo-L-lysine required to be 
antigenic and to elicit delayed hypersensitivity reactions in genetic responder 
guinea pigs.  Immunogenicity was observed with a,N-DNP-hepta,  octa, and 
nona-e-lysine, smaller ce,N-DNP-poly-L-lysines not being  antigenic; delayed 
hypersensitivity reactions could be elicited only with a, N-DNP-PLL contain- 
ing  the  same minimum number  of lysines. Both  observations can probably 
best be explained by the marked immunological specificity of delayed hyper- 
sensitivity reactions, of which carrier specificity is an example. Delayed hyper- 
sensitivity reactions, being the result of the interaction of sensitized cells with 
antigen, have the same strict immunological specificity as the anamnestic re- 
sponse (40) and the proliferative response of sensitized cells to antigen in vitro 
(47). 
The reaction of sensitized cells with antigen requires a  considerable energy 
of interaction which can be provided only by the immunizing antigen at the 
concentration generally used. These considerations imply that the nonresponder 
guinea pigs which were induced to make DNP-PLL antibodies by the injection 
of the polymer complexed with foreign albumins, in fact never made an immune 
response to  the DNP-PLL determinant alone (of which they are  genetically 
incapable) but made it rather to some determinant involving both a portion of 
the DNP-PLL and a portion of the foreign albumin used as carrier. The fact 
that the anfi-DNP antibodies produced by these  animals  showed  specificity 
for the PLL molecule by the technique of fluorescence quenching is in apparent 
contradiction with this interpretation. However, it must be pointed out that 
although this technique demonstrates clearly that these antibodies show speci- 
ficity for PLL, it does not provide an exact measurement of the total specificity 
involved because  of the  nature of  the  technique  (29)  and  because  DNP0.~- 
PLLu0 which had to be used for these measurements must be considered an 
antigen cross-reactive with the more highly coupled DNP-PLL used for im- 
munization. 
In the foregoing discussion we have assumed that the "Schlepper" in DNP- 
PLL protein  complexes  induces  the  formation  of  anti-DNP  antibodies  by 
forming with the hapten a  complete antigenic determinant, similar to what 
occurs with hapten covalently bound with  a  carrier protein.  An  alternative 
possibility has  to be  considered: that is,  that  the electrostatically combined 
antigenic Schlepper molecule initiates the formation of antibodies to the hap- 
tenic  determinants  without at  all being  involved in  the  specificity of  these IRA GREEN, WILLIAM  E.  PAUL, AND BARUJ BENACERRAF  877 
antibodies, or being itself a part of the determinant; the recognition of anti- 
genic protein  being  sufficient to  induce  (through mechanisms unknown)  an 
immune response to haptens introduced with them into susceptible cells. 
SIYMMARY 
30 to 40 % of Harfley strain guinea pigs have previously been demonstrated 
to possess a  dominant autosomal gene which enables them to recognize the 
antigenicity of hapten-poly-L-lysine conjugates as expressed by the develop- 
ment of both antihapten antibodies and delayed hypersensitivity to the  im- 
munizing antigen.  In  the present study, it was shown that PLL  alone  was 
weakly antigenic in such genetic responder animals. Immunization with DNP- 
PLL electrostatically combined with foreign albumins elicits the production of 
anti-DNP antibodies in all Hartley strain guinea pigs, although the percentage 
of animals demonstrating a delayed response to DNP-PLL and therefore con- 
sidered genetic responders  remains 30  to 40%.  Immunization with nonanti- 
genic polyanions combined with DNP-PLL does not produce such an effect. 
Some degree of PLL specificity of purified anfi-DNP antibodies produced by 
genetic  nonresponder  animals  by  immunization  with  DNP-PLL  combined 
with foreign albumins was demonstrated by means of fluorescence quenching. 
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